BMEA
Biomea Fusion, Inc. · Healthcare
A2A Pharmaceuticals, Inc. sold $4.3M of Biomea Fusion, Inc.
10% owner
Sold$4,263,915
$34.11Price
125,000Shares
−3%Stake
What BMEA did after the filing
- The stock from Fri, Jun 2 close, $35.80
- −38.5%
- S&P 500, same days
- +6.5%
Measured over 30 trading days, to the Jul 18 close.
Traded Wed, May 31. Filed Fri, Jun 2, 1:00 PM ET, during the session. Returns use the Jun 2 close and the Jul 18 close. Not investment advice.